Thus, both in vitro and in vivo data strongly suggest that NCTD alone and in combination with crizotinib inhibits tumor growth by autophagic cell death secondary to downregulation of c-Met signaling and subsequent inactivation of mTOR. This evidence concerns the gene MET and neoplasm.